CMS Open Payments · Program Year 2024
Channel Medsystems, Inc.
Channel Medsystems, Inc. reported $194,341.76 across General Payments, Research, and Ownership to 521 physicians and teaching hospitals across 521 transactions.
- $194.3K Below-median payer
- All-tracks total
- 521 Above-median volume
- Transactions
- 521 Above-median reach
- Recipients
- −$88.3K
- General Payments vs PY2023
Channel Medsystems, Inc. reported $194,341.76 across all CMS Open Payments tracks (General + Research + Ownership) to 521 physicians and teaching hospitals in Program Year 2024 - ranking #1009 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $194,341.76, averaging $373.02 per recipient.
How Channel Medsystems, Inc.'s $194.3K all-tracks total breaks down
Channel Medsystems, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
19/100
Total payments
F
12/100
Transaction volume
F
14/100
Physician reach
F
14/100
Payment type diversity
F
37/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer channel-medsystems-inc Channel Medsystems, Inc.
$194.3K · #1009/1,925 · 0.0% industry · PY2024
- TOT $194.3K
- RANK #1009
- SHARE 0.0%
- TXN 521
- RCP 521
- CAT 3
- GEN $194.3K
- ΔGEN −$88.3K
- TOP1 73.4%
- PY 2024
Volume peers
Nearest volume peer: Sequence LifeScience, Inc ($194.5K)
Channel Medsystems, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Channel Medsystems, Inc.'s CMS-reported General Payments decreased by $88.3K (−31.2%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: CHANNEL MEDSYSTEMS, INC.PY2023: CHANNEL MEDSYSTEMS, INC.PY2024: Channel Medsystems, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $282,604.36
- PY2024
- $194,341.76
What the Data Shows for Channel Medsystems, Inc.
The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For Channel Medsystems, Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.
30 transactions worth $181.3K make "Consulting Fee" the top general-payment category in the 3-category breakdown below, 93.3% of General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
"Consulting Fee" leads Channel Medsystems, Inc.'s 3-category general-payment breakdown at $181.3K, 93.3% of the reported total.
How Channel Medsystems, Inc. divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $181.3K | 30 | 93.3% |
| Food and Beverage | $13.0K | 490 | 6.7% |
| Gift | $8.58 | 1 | 0.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $181,428.42 (93.4%) of $194,341.76 in this company's General Payments records across 464 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Channel Medsystems, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Barbara Levy
$142,665.00 across 12 reported transactions
- 2
Andrew Brill
$35,000.00 across 14 reported transactions
- 3
Leslie Hansen-Lindner
$1,752.86 across 3 reported transactions
- 4
William Salter
$1,010.56 across 2 reported transactions
- 5
Taraneh Shirazian
$1,000.00 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Channel Medsystems, Inc. ranks #1009 of 1,925 by total payments (bottom 48% by spend) but is notably more concentrated than that alone would suggest -- #280 of 1,838 by HHI (top 15% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- Hubly Incorporated : $205.53 total payments, HHI 5839
- New York Blood Center, Inc. : $184.6K total payments, HHI 5838
- Mylan Pharmaceuticals Inc. : $379.70 total payments, HHI 5777
- Novo Nordisk US Research & Development, Inc. : $7.8K total payments, HHI 5774
- Spinevision SAS : $66.0K total payments, HHI 5765
- Cook Medical LLC : $2.8M total payments, HHI 5718
- Channel Medsystems, Inc. (this company) : $194.3K total payments, HHI 5715
- Adagio Medical, Inc. : $49.5K total payments, HHI 5713
- Radical Catheter Technologies, Inc. : $15.2K total payments, HHI 5702
- Halozyme Inc : $56.0K total payments, HHI 5678
- Laminate Medical Technologies inc. : $37.7K total payments, HHI 5660
- OrthoXel Designated Activity Company : $10.4K total payments, HHI 5646
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Channel Medsystems, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Channel Medsystems, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Channel Medsystems, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Medicem Inc.
Pulpdent Corporation
NanoFuse Biologics LLC
Carestream Health, Inc.
Vapotherm Inc
Put this to use
Channel Medsystems, Inc. ranks #1009 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Channel Medsystems, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.